Legal & General Group’s Orthofix Medical OFIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $37.2K | Buy |
4,070
+537
| +15% | +$5.92K | ﹤0.01% | 2876 |
|
|
2026
Q1 | $40.5K | Hold |
3,533
| – | – | ﹤0.01% | 2728 |
|
|
2025
Q4 | $53.6K | Hold |
3,533
| – | – | ﹤0.01% | 2715 |
|
|
2025
Q3 | $51.7K | Sell |
3,533
-32,600
| -90% | -$428K | ﹤0.01% | 2724 |
|
|
2025
Q2 | $403K | Buy |
36,133
+498
| +1% | +$6.17K | ﹤0.01% | 2498 |
|
|
2025
Q1 | $581K | Buy |
35,635
+3,653
| +11% | +$64.1K | ﹤0.01% | 2349 |
|
|
2024
Q4 | $558K | Sell |
31,982
-2
| -0% | -$35 | ﹤0.01% | 2419 |
|
|
2024
Q3 | $500K | Hold |
31,984
| – | – | ﹤0.01% | 2458 |
|
|
2024
Q2 | $424K | Hold |
31,984
| – | – | ﹤0.01% | 2470 |
|
|
2024
Q1 | $464K | Hold |
31,984
| – | – | ﹤0.01% | 2459 |
|
|
2023
Q4 | $431K | Sell |
31,984
-66,817
| -68% | -$785K | ﹤0.01% | 2516 |
|
|
2023
Q3 | $1.27M | Buy |
98,801
+6,248
| +7% | +$112K | ﹤0.01% | 2099 |
|
|
2023
Q2 | $1.67M | Buy |
92,553
+11,351
| +14% | +$212K | ﹤0.01% | 1999 |
|
|
2023
Q1 | $1.36M | Buy |
81,202
+32,659
| +67% | +$639K | ﹤0.01% | 2045 |
|
|
2022
Q4 | $997K | Buy |
48,543
+1,265
| +3% | +$22.3K | ﹤0.01% | 2162 |
|
|
2022
Q3 | $904K | Sell |
47,278
-1,058
| -2% | -$23.8K | ﹤0.01% | 2176 |
|
|
2022
Q2 | $1.14M | Buy |
48,336
+485
| +1% | +$13.9K | ﹤0.01% | 2115 |
|
|
2022
Q1 | $1.56M | Sell |
47,851
-10,123
| -17% | -$325K | ﹤0.01% | 2083 |
|
|
2021
Q4 | $1.8M | Buy |
57,974
+1,574
| +3% | +$52.6K | ﹤0.01% | 2067 |
|
|
2021
Q3 | $2.15M | Buy |
56,400
+4,350
| +8% | +$173K | ﹤0.01% | 1995 |
|
|
2021
Q2 | $2.09M | Sell |
52,050
-13,127
| -20% | -$555K | ﹤0.01% | 1951 |
|
|
2021
Q1 | $2.83M | Buy |
65,177
+7,039
| +12% | +$310K | ﹤0.01% | 1832 |
|
|
2020
Q4 | $2.5M | Buy |
58,138
+56
| +0.1% | +$2.05K | ﹤0.01% | 1790 |
|
|
2020
Q3 | $1.81M | Buy |
58,082
+770
| +1% | +$23.9K | ﹤0.01% | 1802 |
|
|
2020
Q2 | $1.83M | Buy |
57,312
+3,513
| +7% | +$117K | ﹤0.01% | 1769 |
|
|
2020
Q1 | $1.51M | Buy |
53,799
+274
| +0.5% | +$10.6K | ﹤0.01% | 1699 |
|
|
2019
Q4 | $2.47M | Buy |
53,525
+3,172
| +6% | +$149K | ﹤0.01% | 1696 |
|
|
2019
Q3 | $2.67M | Buy |
50,353
+1,830
| +4% | +$94.4K | ﹤0.01% | 1591 |
|
|
2019
Q2 | $2.57M | Sell |
48,523
-199
| -0.4% | -$10.6K | ﹤0.01% | 1589 |
|
|
2019
Q1 | $2.75M | Buy |
48,722
+4,452
| +10% | +$250K | ﹤0.01% | 1546 |
|
|
2018
Q4 | $2.33M | Buy |
44,270
+180
| +0.4% | +$10.2K | ﹤0.01% | 1512 |
|
|
2018
Q3 | $2.54M | Buy |
44,090
+3,355
| +8% | +$188K | ﹤0.01% | 1584 |
|
|
2018
Q2 | $2.33M | Buy |
40,735
+3,205
| +9% | +$182K | ﹤0.01% | 1595 |
|
|
2018
Q1 | $2.2M | Buy |
37,530
+941
| +3% | +$52.7K | ﹤0.01% | 1571 |
|
|
2017
Q4 | $2M | Buy |
36,589
+202
| +0.6% | +$10.5K | ﹤0.01% | 1621 |
|
|
2017
Q3 | $1.72M | Buy |
36,387
+1,973
| +6% | +$92.9K | ﹤0.01% | 1659 |
|
|
2017
Q2 | $1.6M | Buy |
34,414
+3,454
| +11% | +$143K | ﹤0.01% | 1639 |
|
|
2017
Q1 | $1.18M | Buy |
30,960
+24,743
| +398% | +$916K | ﹤0.01% | 1733 |
|
|
2016
Q4 | $224K | Buy |
+6,217
| New | +$236K | ﹤0.01% | 2201 |
|
Other funds holding OFIX
ECM
JIC
RCMNY
PCMI
AC
Legal & General Group's OFIX Position: Q2 2026 in Review
Legal & General Group increased its Orthofix Medical (OFIX) stake by 15% in Q2 2026, buying an estimated $5.92K and bringing the position to 4,070 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2876.
Legal & General Group first reported a position in OFIX in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.83M in Q1 2021. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.
- Legal & General Group held 4,070 shares of Orthofix Medical worth $37.2K as of Q2 2026.
- Legal & General Group bought 537 Orthofix Medical shares in Q2 2026, an estimated $5.92K.
- Orthofix Medical made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2876 holding.
- Legal & General Group first reported a position in Orthofix Medical in Q4 2016 and has held it in 39 quarters since.
- Legal & General Group's Orthofix Medical position peaked at $2.83M in Q1 2021.
- 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.